nitazoxanide
Commercial- Indications
- Anti-parasitic
Company intelligence / Profile preview
Biophore is a leading global developer and manufacturer of complex Active Pharmaceutical Ingredients (APIs) with over four US FDA/EU-approved manufacturing facilities. The company has more than 200 products in its portfolio across oncology, rare diseases, contrast agents, peptides, hormones/steroids, and injectable APIs. Several products have reached commercial status globally; notable approvals include cannabinoids for neurological disorders and nirmatrelvir/ritonavir for COVID treatment as part of Paxlovid. The company is recognized as one of the top US DMF filers in recent years.[1][3][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biophore.